about
Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the LiteraturePhase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer.Cuprous oxide nanoparticles inhibit the growth of cervical carcinoma by inducing autophagyProteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors.MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
P2860
Q28067445-9496C9FE-9B96-4630-8CE1-2F3932DB8AD4Q33614537-3AF04005-64F4-4FCF-8C31-22C2BD7930BEQ41882577-99E50062-5D1F-4B6F-B872-4A3925EF22F7Q42378347-38FCB9EC-D1D2-4CC2-9FAD-F8641DD41C89Q47100939-C8861485-404E-495E-B5E1-0450FD51AC4FQ47321072-F54DBDFD-8CB1-4FD2-A015-7C8A954DB7B5Q52747351-8E5180AC-EBB1-4432-9440-8129732A082CQ58773654-B5C5A05D-A200-443D-B9CF-600551CC714C
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
mTOR inhibitors in urinary bladder cancer.
@en
type
label
mTOR inhibitors in urinary bladder cancer.
@en
prefLabel
mTOR inhibitors in urinary bladder cancer.
@en
P2093
P2860
P1433
P1476
mTOR inhibitors in urinary bladder cancer
@en
P2093
Nuno Sousa
R Arantes-Rodrigues
R Pinto-Leite
P2860
P2888
P304
11541-11551
P356
10.1007/S13277-016-5083-1
P577
2016-05-27T00:00:00Z
P6179
1034830116